Clarient Acquires Applied Genomics
Clarient Inc has announced that it has acquired privately held, Huntsville, Ala-based Applied Genomics Inc (AGI) in an all-stock merger valued at up to $17.6 million.
Read MoreSearch Results for: lung cancer
Clarient, BioView Work to Finalize Lung Cancer Molecular Diagnostic Test
Posted by Clinical Lab Products | Dec 15, 2009 | Cancer, Lung Cancer, Molecular Diagnostics |
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
Read MoreBiomoda, Christiana Care Partner to Complete Pilot Study on Cancer Diagnostic
Posted by Clinical Lab Products | Dec 11, 2009 | Cancer, Miscellaneous |
The Helen F. Graham Cancer Center associated with Christiana Care Health System will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath assay, an early-stage diagnostic test for lung cancer.
Read MoreTransgenomic Launches SURVEYOR Scan K-RAS Mutation Detection Kit
Posted by Clinical Lab Products | Dec 9, 2009 | Cancer, Miscellaneous |
Transgenomic announced the launch of its SURVEYOR Scan K-RAS kit, the first in a family of mutation detection kits the company plans to offer featuring its proprietary SURVEYOR Nuclease and WAVE HS DHPLC platform.
Read MoreNew technology Defines New Prostate-specific Antigen Zero
Posted by Clinical Lab Products | Oct 21, 2009 | Cancer, Miscellaneous |
A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Read More